Xeriant Inc (XERI) Stock Analysis
Verdict: AVOID
Technically insolvent pre-revenue shell with a 0.005 current ratio; capital preservation requires total avoidance despite 'Halo' IP.
Investment score: 12/100
Analysis as of
Is Xeriant Inc stock worth reviewing? The TradeMates thesis
The model views XERI as a high-risk micro-cap in a state of technical insolvency, lacking revenue and holding unsustainable debt.
7-factor investment score
- Valuation: 5/100 (weight 20%)
- Financial Health: 2/100 (weight 15%)
- Technical Momentum: 30/100 (weight 15%)
- Earnings Quality: 5/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 10/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Xeriant Inc opportunities and risks
What speaks for XERI
- Halo Patent Monetization
What speaks against XERI
- Imminent Liquidity Failure
Peers and competitors
- CVU
- VTSI
- EXYN
- OPST
- ETCC
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| XERI | 8.8x | 207.7x | n/a | 43.2% | 1770.1% | -5.7% |
| CVU | 33.6x | 0.9x | 28.9x | 18.8% | 2.4% | -4.8% |
| VTSI | n/a | 1.9x | n/a | 64.9% | -12.5% | 1.4% |
| EXYN | n/a | 3.6x | n/a | 36.0% | -209.8% | -40.5% |
| OPST | 16.7x | 2.6x | 11.1x | 34.8% | 15.8% | 4.0% |
| ETCC | 15.7x | 0.2x | 4.2x | 27.4% | 3.2% | 22.5% |
| Peer median | 15.7x | 1.9x | 4.2x | 34.8% | 2.4% | 1.4% |
Frequently asked questions about Xeriant Inc (XERI)
Is XERI stock a good investment?
The TradeMates model rates Xeriant Inc as AVOID with an investment score of 12/100. The model views XERI as a high-risk micro-cap in a state of technical insolvency, lacking revenue and holding unsustainable debt. This is algorithmic model output, not personal investment advice.
Is XERI stock a buy?
The TradeMates model verdict for XERI is AVOID with an investment score of 12/100. Treat this as a model signal to review, not a personal buy recommendation.